{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:15:39Z","timestamp":1772792139022,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2023682"],"award-info":[{"award-number":["BE2023682"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["111-2-06"],"award-info":[{"award-number":["111-2-06"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21907038"],"award-info":[{"award-number":["21907038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004028","name":"Jiangnan University","doi-asserted-by":"publisher","award":["JUSRP12016"],"award-info":[{"award-number":["JUSRP12016"]}],"id":[{"id":"10.13039\/501100004028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016337","name":"Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education","doi-asserted-by":"publisher","award":["KLCCB-KF202304"],"award-info":[{"award-number":["KLCCB-KF202304"]}],"id":[{"id":"10.13039\/501100016337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ab.2025.115951","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T23:39:02Z","timestamp":1753918742000},"page":"115951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A modular and universal platform for neutralizing-antibody profiling by quantifying antigen-receptor interactions via qPCR"],"prefix":"10.1016","volume":"706","author":[{"given":"Xia","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yating","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haofei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4310-5326","authenticated-orcid":false,"given":"Jie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ab.2025.115951_bib1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41577-023-00858-w","article-title":"Antiviral neutralizing antibodies: from in vitro to in vivo activity","volume":"23","author":"Burton","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.ab.2025.115951_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12026-020-09159-z","article-title":"Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview","volume":"68","author":"Ali","year":"2020","journal-title":"Immunol. Res."},{"issue":"5","key":"10.1016\/j.ab.2025.115951_bib3","first-page":"1770","article-title":"Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis","volume":"26","author":"Huang","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.ab.2025.115951_bib4","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1089\/pop.2022.0078","article-title":"COVID-19 vaccination, morbidity, and mortality during a 12-Month period in Israel: can we maintain a \"Herd Immunity\" state?","volume":"25","author":"Saban","year":"2022","journal-title":"Popul. Health Manag."},{"key":"10.1016\/j.ab.2025.115951_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069761","article-title":"Influenza, and N. Other viruses in the acutely ill, clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, Delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study","volume":"376","author":"Lauring","year":"2022","journal-title":"Br. Med. J."},{"issue":"12","key":"10.1016\/j.ab.2025.115951_bib6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3390\/vaccines9121376","article-title":"Overview of neutralizing antibodies and their potential in COVID-19","volume":"9","author":"Morales-N\u00fa\u00f1ez","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"7807","key":"10.1016\/j.ab.2025.115951_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ab.2025.115951_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41423-020-0458-z","article-title":"Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies","volume":"17","author":"Yi","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"600","key":"10.1016\/j.ab.2025.115951_bib9","doi-asserted-by":"crossref","first-page":"eabi9915","DOI":"10.1126\/scitranslmed.abi9915","article-title":"Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection","volume":"13","author":"Greaney","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.ab.2025.115951_bib10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","article-title":"Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.ab.2025.115951_bib11","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ab.2025.115951_bib12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ab.2025.115951_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-94317-2","article-title":"A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samples","volume":"15","author":"Atarashi","year":"2025","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.ab.2025.115951_bib14","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.3390\/ijms26094064","article-title":"Impact of SARS-CoV-2 RBM mutations N501Y and E484K on ACE2 binding: a combined computational and experimental study","volume":"26","author":"Rombel-Bryzek","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"7807","key":"10.1016\/j.ab.2025.115951_bib15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ab.2025.115951_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41541-021-00393-6","article-title":"Scientific rationale for developing potent RBD-Based vaccines targeting COVID-19","volume":"6","author":"Kleanthous","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"7","key":"10.1016\/j.ab.2025.115951_bib17","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.ab.2025.115951_bib18","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1093\/cid\/ciz1198","article-title":"Neutralizing and neuraminidase antibodies correlate with protection against influenza during a late season A\/H3N2 outbreak among unvaccinated military recruits","volume":"71","author":"Weiss","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ab.2025.115951_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41541-022-00470-4","article-title":"Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies","volume":"7","author":"Sanyal","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"4","key":"10.1016\/j.ab.2025.115951_bib20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/cid\/ciae537","article-title":"Long-term dynamics of measles virus-specific neutralizing antibodies in children vaccinated before 12 months of age","volume":"80","author":"van der Staak","year":"2025","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.ab.2025.115951_bib21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.ab.2025.115951_bib22","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/cid\/ciab381","article-title":"Age-dependent immune response to the biontech\/pfizer BNT162b2 coronavirus disease 2019 vaccination","volume":"73","author":"M\u00fcller","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ab.2025.115951_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068632","article-title":"Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis","volume":"376","author":"Lee","year":"2022","journal-title":"Br. Med. J."},{"issue":"2","key":"10.1016\/j.ab.2025.115951_bib24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41435-023-00219-6","article-title":"Boosting SARS-CoV-2 immunity in immunocompromised individuals","volume":"25","author":"M\u00fcller","year":"2024","journal-title":"Gene Immun."},{"issue":"6","key":"10.1016\/j.ab.2025.115951_bib25","article-title":"Why promoting a COVID-19 vaccine booster dose?","volume":"40","author":"Loubet","year":"2021","journal-title":"Anaesth. Crit. Care Pain Med."},{"issue":"1","key":"10.1016\/j.ab.2025.115951_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.vaccine.2023.11.047","article-title":"The relative effectiveness of three and four doses of COVID-19 vaccine in Victoria, Australia: a data linkage study","volume":"42","author":"Canevari","year":"2024","journal-title":"Vaccine"},{"issue":"10298","key":"10.1016\/j.ab.2025.115951_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(21)01642-1","article-title":"Spike-antibody waning after second dose of BNT162b2 or ChAdOx1","volume":"398","author":"Shrotri","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ab.2025.115951_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106345","article-title":"Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost","volume":"26","author":"Nair","year":"2023","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.ab.2025.115951_bib29","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s11596-021-2470-7","article-title":"Recent developments in SARS-CoV-2 neutralizing antibody detection methods","volume":"41","author":"Banga Ndzouboukou","year":"2021","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.ab.2025.115951_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2023.115199","article-title":"Research progress in methods for detecting neutralizing antibodies against SARS-CoV-2","volume":"673","author":"Chen","year":"2023","journal-title":"Anal. Biochem."},{"issue":"6515","key":"10.1016\/j.ab.2025.115951_bib31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.abd9909","article-title":"De novo design of picomolar SARS-CoV-2 miniprotein inhibitors","volume":"370","author":"Cao","year":"2020","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.ab.2025.115951_bib32","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.xphs.2022.07.017","article-title":"Repurposing the pentameric B-Subunit of Shiga toxin for Gb3-Targeted immunotherapy of colorectal cancer by rhamnose conjugation","volume":"111","author":"Liu","year":"2022","journal-title":"J. Pharmaceut. Sci."},{"issue":"10","key":"10.1016\/j.ab.2025.115951_bib33","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/s41564-022-01235-4","article-title":"SARS-CoV-2 Delta and omicron variants evade population antibody response by mutations in a single spike epitope","volume":"7","author":"He","year":"2022","journal-title":"Nat. Microbiol."},{"issue":"9","key":"10.1016\/j.ab.2025.115951_bib34","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","volume":"184","author":"McCallum","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.ab.2025.115951_bib35","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41423-022-00890-1","article-title":"Neutralizing antibodies and their cocktails against SARS-CoV-2 omicron and other circulating variants","volume":"19","author":"Yang","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.ab.2025.115951_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41467-020-20321-x","article-title":"Stabilizing the closed SARS-CoV-2 spike trimer","volume":"12","author":"Juraszek","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269725001903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269725001903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:28:56Z","timestamp":1772782136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269725001903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":36,"alternative-id":["S0003269725001903"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2025.115951","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A modular and universal platform for neutralizing-antibody profiling by quantifying antigen-receptor interactions via qPCR","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2025.115951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115951"}}